- Home
- ALUR vs GRFX Comparison
ALUR vs GRFX Comparison
Compare ALUR & GRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALUR
- GRFX
- Stock Information
- Founded
- ALUR 2009
- GRFX 1981
- Country
- ALUR United States
- GRFX Hong Kong
- Employees
- ALUR N/A
- GRFX N/A
- Industry
- ALUR
- GRFX
- Sector
- ALUR
- GRFX
- Exchange
- ALUR Nasdaq
- GRFX Nasdaq
- Market Cap
- ALUR 22.5M
- GRFX 18.1M
- IPO Year
- ALUR N/A
- GRFX N/A
- Fundamental
- Price
- ALUR $2.93
- GRFX $0.31
- Analyst Decision
- ALUR Strong Buy
- GRFX Hold
- Analyst Count
- ALUR 4
- GRFX 1
- Target Price
- ALUR $75.00
- GRFX N/A
- AVG Volume (30 Days)
- ALUR 101.1K
- GRFX 1.9M
- Earning Date
- ALUR 11-13-2024
- GRFX 01-01-0001
- Dividend Yield
- ALUR N/A
- GRFX N/A
- EPS Growth
- ALUR N/A
- GRFX N/A
- EPS
- ALUR N/A
- GRFX N/A
- Revenue
- ALUR $34,754,000.00
- GRFX $30,019,108.00
- Revenue This Year
- ALUR N/A
- GRFX N/A
- Revenue Next Year
- ALUR $2.22
- GRFX N/A
- P/E Ratio
- ALUR N/A
- GRFX N/A
- Revenue Growth
- ALUR N/A
- GRFX N/A
- 52 Week Low
- ALUR $2.37
- GRFX $0.14
- 52 Week High
- ALUR $98.75
- GRFX $0.94
- Technical
- Relative Strength Index (RSI)
- ALUR 27.81
- GRFX 53.62
- Support Level
- ALUR $2.72
- GRFX $0.28
- Resistance Level
- ALUR $4.20
- GRFX $0.34
- Average True Range (ATR)
- ALUR 1.92
- GRFX 0.08
- MACD
- ALUR -0.52
- GRFX -0.00
- Stochastic Oscillator
- ALUR 4.95
- GRFX 16.03
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
About GRFX Graphex Group Limited each representing 20
Graphex Group Ltd is engaged in the sale of graphene products. It operates in three segments namely, the Graphene Products Segment includes Processing and sale of graphite and graphene-related products; the Landscape Architecture Design Segment includes Providing landscape architecture design; and the catering business focuses on the operation of restaurants. The company derives the majority of its revenue from the sale of graphene products segment.